论文部分内容阅读
目的：判定立克菌星在治疗呼吸道感染中的作用。方法：利用立克菌星和硫酸妥布霉素治疗呼吸道细菌感染，然后进行两药的临床疗效及对不同致病菌的疗效比较及对致病菌的清除率比较。结果：立克菌星和硫酸妥布霉素的有效率分别为 ８２９％ 和 ６８４％ 。对不同致病菌的有效率分别为８８６％ 和６２５％ 。致病菌清除 为８０％ 和 ５６３％ 。结论：立克菌星治疗呼吸道细菌感染的临床有效率、对不同致病菌的有效率和致病菌的清除率明显优于硫酸妥布霉素。
Objective: To determine the role of rickettsia in the treatment of respiratory tract infections. Methods: The use of Rickettsia bacteria and tobramycin sulfate treatment of respiratory tract bacterial infections, and then the clinical efficacy of two drugs and the efficacy of different pathogenic bacteria compared to the clearance rate of pathogens. Results: The effective rates of rickettsia and tobramycin sulfate were 829% and 684% respectively. The efficiency of different pathogenic bacteria were 88 6% and 62 5%. Pathogen clearance was 80% and 56 3%. Conclusion: The clinical efficacies of Rickettsiella pneumoniae in the treatment of respiratory tract bacterial infections were significantly better than those of tobramycin sulfate for different pathogenic bacteria and pathogenic bacteria.